β2-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein

Ching Huang Wu, Mojgan Rastegar, John Gordon, Ahmad Safa

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

In this study, we examined whether exogenous β2-microglobulin (β2m) can induce apoptosis in the drug sensitive HL-60 leukemia cell line and its drug resistant variants and investigated the molecular mechanism of β2m-induced apoptosis. Our data revealed that β2m is very significantly down-regulated in two multidrug resistant variants of the HL-60 cells: (a) the MRP1-bearing, Bax-deficient HL-60/ADR cell line, and (b) the P-glycoprotein (P-gp) overexpressing HL-60/VCR cell line. However, exogenous β2m induced similar levels of apoptosis in HL-60 cells and these drug resistant variants. β2m-induced apoptosis in HL-60 and HL-60/VCR cells was associated with decreased mitochondrial membrane potential (Δψm) but did not affect Δψm in HL-60/ADR cells. Surprisingly, cyclosporin A (CsA), a known inhibitor of the mitochondrial permeability transition (MPT) pore, inhibited β2m-induced apoptosis in HL-60/ADR cells but not in HL-60 and HL-60/VCR cells, suggesting that the pro-apoptotic effect of β2m in these cells is not through MPT pore formation. Furthermore, β2m induced the release of cytochrome c and the apoptosis-inducing factor (AIF) from mitochondria in HL-60 and HL-60/VCR cells, but not in HL-60/ADR cells. Additionally, z-VAD-fmk, a general inhibitor of caspases which inhibited cytochrome c release in HL-60 and HL-60/VCR cells, had no effect on AIF release in any of these cell lines, but inhibited β2m-induced apoptosis in all three cell lines. However, Western blot analysis revealed that caspases-1, -3, -6, -8, and -9 are not activated during β2m-induced apoptosis in these cells. Therefore, β2m-induces apoptosis through an unknown caspase-dependent mitochondrial pathway in HL-60 and HL-60/VCR cells and by a Bax-independent, nonmitochodrial, caspase-dependent pathway in HL-60/ADR cells.

Original languageEnglish
Pages (from-to)7006-7020
Number of pages15
JournalOncogene
Volume20
Issue number48
DOIs
StatePublished - Oct 25 2001

Fingerprint

HL-60 Cells
P-Glycoprotein
Leukemia
Apoptosis
Cell Line
Apoptosis Inducing Factor
Caspases
Cytochromes c
Pharmaceutical Preparations
Caspase 1
Caspase Inhibitors
Mitochondrial Membrane Potential
Caspase 3
Cyclosporine
Mitochondria

Keywords

  • β-microglobulin
  • Apoptosis
  • Caspases
  • Leukemia
  • Multidrug resistance

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

β2-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein. / Wu, Ching Huang; Rastegar, Mojgan; Gordon, John; Safa, Ahmad.

In: Oncogene, Vol. 20, No. 48, 25.10.2001, p. 7006-7020.

Research output: Contribution to journalArticle

@article{5d9b9d16c9e24fc9a807b63e3d13218f,
title = "β2-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein",
abstract = "In this study, we examined whether exogenous β2-microglobulin (β2m) can induce apoptosis in the drug sensitive HL-60 leukemia cell line and its drug resistant variants and investigated the molecular mechanism of β2m-induced apoptosis. Our data revealed that β2m is very significantly down-regulated in two multidrug resistant variants of the HL-60 cells: (a) the MRP1-bearing, Bax-deficient HL-60/ADR cell line, and (b) the P-glycoprotein (P-gp) overexpressing HL-60/VCR cell line. However, exogenous β2m induced similar levels of apoptosis in HL-60 cells and these drug resistant variants. β2m-induced apoptosis in HL-60 and HL-60/VCR cells was associated with decreased mitochondrial membrane potential (Δψm) but did not affect Δψm in HL-60/ADR cells. Surprisingly, cyclosporin A (CsA), a known inhibitor of the mitochondrial permeability transition (MPT) pore, inhibited β2m-induced apoptosis in HL-60/ADR cells but not in HL-60 and HL-60/VCR cells, suggesting that the pro-apoptotic effect of β2m in these cells is not through MPT pore formation. Furthermore, β2m induced the release of cytochrome c and the apoptosis-inducing factor (AIF) from mitochondria in HL-60 and HL-60/VCR cells, but not in HL-60/ADR cells. Additionally, z-VAD-fmk, a general inhibitor of caspases which inhibited cytochrome c release in HL-60 and HL-60/VCR cells, had no effect on AIF release in any of these cell lines, but inhibited β2m-induced apoptosis in all three cell lines. However, Western blot analysis revealed that caspases-1, -3, -6, -8, and -9 are not activated during β2m-induced apoptosis in these cells. Therefore, β2m-induces apoptosis through an unknown caspase-dependent mitochondrial pathway in HL-60 and HL-60/VCR cells and by a Bax-independent, nonmitochodrial, caspase-dependent pathway in HL-60/ADR cells.",
keywords = "β-microglobulin, Apoptosis, Caspases, Leukemia, Multidrug resistance",
author = "Wu, {Ching Huang} and Mojgan Rastegar and John Gordon and Ahmad Safa",
year = "2001",
month = "10",
day = "25",
doi = "10.1038/sj.onc.1204893",
language = "English",
volume = "20",
pages = "7006--7020",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "48",

}

TY - JOUR

T1 - β2-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein

AU - Wu, Ching Huang

AU - Rastegar, Mojgan

AU - Gordon, John

AU - Safa, Ahmad

PY - 2001/10/25

Y1 - 2001/10/25

N2 - In this study, we examined whether exogenous β2-microglobulin (β2m) can induce apoptosis in the drug sensitive HL-60 leukemia cell line and its drug resistant variants and investigated the molecular mechanism of β2m-induced apoptosis. Our data revealed that β2m is very significantly down-regulated in two multidrug resistant variants of the HL-60 cells: (a) the MRP1-bearing, Bax-deficient HL-60/ADR cell line, and (b) the P-glycoprotein (P-gp) overexpressing HL-60/VCR cell line. However, exogenous β2m induced similar levels of apoptosis in HL-60 cells and these drug resistant variants. β2m-induced apoptosis in HL-60 and HL-60/VCR cells was associated with decreased mitochondrial membrane potential (Δψm) but did not affect Δψm in HL-60/ADR cells. Surprisingly, cyclosporin A (CsA), a known inhibitor of the mitochondrial permeability transition (MPT) pore, inhibited β2m-induced apoptosis in HL-60/ADR cells but not in HL-60 and HL-60/VCR cells, suggesting that the pro-apoptotic effect of β2m in these cells is not through MPT pore formation. Furthermore, β2m induced the release of cytochrome c and the apoptosis-inducing factor (AIF) from mitochondria in HL-60 and HL-60/VCR cells, but not in HL-60/ADR cells. Additionally, z-VAD-fmk, a general inhibitor of caspases which inhibited cytochrome c release in HL-60 and HL-60/VCR cells, had no effect on AIF release in any of these cell lines, but inhibited β2m-induced apoptosis in all three cell lines. However, Western blot analysis revealed that caspases-1, -3, -6, -8, and -9 are not activated during β2m-induced apoptosis in these cells. Therefore, β2m-induces apoptosis through an unknown caspase-dependent mitochondrial pathway in HL-60 and HL-60/VCR cells and by a Bax-independent, nonmitochodrial, caspase-dependent pathway in HL-60/ADR cells.

AB - In this study, we examined whether exogenous β2-microglobulin (β2m) can induce apoptosis in the drug sensitive HL-60 leukemia cell line and its drug resistant variants and investigated the molecular mechanism of β2m-induced apoptosis. Our data revealed that β2m is very significantly down-regulated in two multidrug resistant variants of the HL-60 cells: (a) the MRP1-bearing, Bax-deficient HL-60/ADR cell line, and (b) the P-glycoprotein (P-gp) overexpressing HL-60/VCR cell line. However, exogenous β2m induced similar levels of apoptosis in HL-60 cells and these drug resistant variants. β2m-induced apoptosis in HL-60 and HL-60/VCR cells was associated with decreased mitochondrial membrane potential (Δψm) but did not affect Δψm in HL-60/ADR cells. Surprisingly, cyclosporin A (CsA), a known inhibitor of the mitochondrial permeability transition (MPT) pore, inhibited β2m-induced apoptosis in HL-60/ADR cells but not in HL-60 and HL-60/VCR cells, suggesting that the pro-apoptotic effect of β2m in these cells is not through MPT pore formation. Furthermore, β2m induced the release of cytochrome c and the apoptosis-inducing factor (AIF) from mitochondria in HL-60 and HL-60/VCR cells, but not in HL-60/ADR cells. Additionally, z-VAD-fmk, a general inhibitor of caspases which inhibited cytochrome c release in HL-60 and HL-60/VCR cells, had no effect on AIF release in any of these cell lines, but inhibited β2m-induced apoptosis in all three cell lines. However, Western blot analysis revealed that caspases-1, -3, -6, -8, and -9 are not activated during β2m-induced apoptosis in these cells. Therefore, β2m-induces apoptosis through an unknown caspase-dependent mitochondrial pathway in HL-60 and HL-60/VCR cells and by a Bax-independent, nonmitochodrial, caspase-dependent pathway in HL-60/ADR cells.

KW - β-microglobulin

KW - Apoptosis

KW - Caspases

KW - Leukemia

KW - Multidrug resistance

UR - http://www.scopus.com/inward/record.url?scp=0035950543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035950543&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1204893

DO - 10.1038/sj.onc.1204893

M3 - Article

VL - 20

SP - 7006

EP - 7020

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 48

ER -